Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles from the last 30 days matching "genetic analysis"

ResearchUNITERAREApr 5

New Recruiting Trial: Genetic Analysis of Uncommon Disease Presentations in Non-US Populations

Researchers at the National Human Genome Research Institute are starting a study to understand rare genetic diseases by studying people from countries outside the United States. The study will look at how genetic changes cause unusual disease patterns in different populations. This research could help doctors better understand and diagnose rare diseases worldwide.

WHY IT MATTERSThis trial expands rare disease research beyond US populations, which means genetic discoveries could help patients globally who have been underrepresented in previous studies.
👁 Watch this spaceRead →
ResearchBIORXIVApr 3

Preprint: FA-NIVA: A Nextflow framework for automated analysis of Nanopore based long-read sequencing data for genetic analysis in Fanconi anemia

Scientists created a new computer tool called FA-NIVA that helps doctors find genetic mistakes in Fanconi anemia patients more accurately. Fanconi anemia is a rare inherited blood disorder caused by mistakes in specific genes. This new tool uses advanced DNA sequencing technology that reads longer pieces of DNA, making it easier to spot all types of genetic errors, including big deletions and insertions that older methods sometimes miss.

WHY IT MATTERSThis tool could help doctors diagnose Fanconi anemia more accurately and completely by detecting genetic variants that standard testing methods currently miss, potentially leading to faster diagnosis and better understanding of individual patient mutations.
ℹ Good to knowFanconi anemiaRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases